Skip to content

Public FDA record

Z-0963-2022: The Sight OLO device is a computer vision based platform for blood analysis. The platform combines comput

Recall record Z-0963-2022 for SIGHT DIAGNOSTICS LTD. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0963-2022
Company in FDA record
SIGHT DIAGNOSTICS LTD
FDA record creation date
Apr 21, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

In instances where custom reference ranges were configured on the device post installation, a possibility to inadvertently apply changes to reference range values was found on software versions 2.59.3 and all earlier versions, which can potentially lead to displaying and printing incorrectly-configured reference range values

Source facts

Action
Sight Diagnostics issued Medical Device Recall Notification on 1/20/22 via email to Distributors and End Users. Letter states reason for recall, health risk and action to take: In case you have configured your own reference ranges, please review the configured values to ensure all values are set properly. You can then continue to use your OLO analyzer. The software version of the OLO analyzer in your possession will be updated to a new version that resolves this software defect. The update will be performed remotely by Sights product specialists, who will contact you to schedule the update. Please be aware that the software version update requires the analyzer to be connected to the internet. If you need to make any adjustments to your reference ranges before the software update is performed, please avoid pressing the Cancel button while editing a reference range parameter, and always review all parameters after making any changes, to confirm values are set properly. If you are a distributor, please share this recall notification letter with any customer to whom the product was shipped, or may have been shipped. You are kindly requested to fill the attached Acknowledgement and Receipt Form, and return it to notifications@sightdx.com within 30 days. Software version 2.63 was released and includes the fix for the software defect mentioned above. Questions please contact us at Support@sightdx.com. For full indications for use and safety information please refer to the Quality and Compliance page at www.sightdx.com.
Initiated
2022-01-20
Root cause
Software design
Distribution
Worldwide distribution - US Nationwide and the countries of AUSTRALIA, CANADA, CHILE, CURACAO, FINLAND, GEORGIA, GERMANY, GREECE, HONG KONG, IRELAND, ISRAEL, ITALY, MEXICO, NETHERLANDS, PORTUGAL, SINGAPORE, SLOVENIA, UNITED ARAB EMIRATES, UNITED KINGDOM.
Recall number
Z-0963-2022
Recall status
Open, Classified
CDRH record ID
192103
FDA record created
2022-04-21
Recall event number
89645

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗